HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying-Jan Wang Selected Research

Lung Neoplasms (Lung Cancer)

10/2017P53-dependent downregulation of hTERT protein expression and telomerase activity induces senescence in lung cancer cells as a result of pterostilbene treatment.
1/2017A histone deacetylase inhibitor enhances expression of genes inhibiting Wnt pathway and augments activity of DNA demethylation reagent against nonsmall-cell lung cancer.
1/2017Pterostilbene prevents AKT-ERK axis-mediated polymerization of surface fibronectin on suspended lung cancer cells independently of apoptosis and suppresses metastasis.
4/2014A histone deacetylase inhibitor YCW1 with antitumor and antimetastasis properties enhances cisplatin activity against non-small cell lung cancer in preclinical studies.
1/2014The regulation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumor promotion by estradiol in female A/J mice.
6/2010Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells.
8/2008Rapid activation of Stat3 and ERK1/2 by nicotine modulates cell proliferation in human bladder cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying-Jan Wang Research Topics

Disease

76Neoplasms (Cancer)
11/2021 - 04/2002
27Carcinogenesis
04/2018 - 05/2005
17Inflammation (Inflammations)
01/2022 - 03/2003
10Breast Neoplasms (Breast Cancer)
01/2017 - 02/2007
7Lung Neoplasms (Lung Cancer)
10/2017 - 08/2008
7Leukemia
01/2015 - 10/2004
6Hypersensitivity (Allergy)
11/2018 - 03/2003
6Colonic Neoplasms (Colon Cancer)
01/2011 - 08/2003
6Hepatocellular Carcinoma (Hepatoma)
08/2010 - 09/2004
5Triple Negative Breast Neoplasms
02/2021 - 01/2013
5Skin Diseases (Skin Disease)
01/2017 - 08/2010
4Papilloma (Papillomatosis)
03/2021 - 11/2006
4Neoplasm Metastasis (Metastasis)
01/2018 - 06/2005
4Necrosis
03/2015 - 09/2005
4Prostatic Neoplasms (Prostate Cancer)
05/2013 - 01/2012
4Liver Neoplasms (Liver Cancer)
05/2012 - 05/2009
4Glioma (Gliomas)
09/2011 - 10/2003
3Fibrosis (Cirrhosis)
01/2020 - 04/2008
3Mouth Neoplasms (Oral Cancer)
10/2019 - 08/2003
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2019 - 11/2005
3Contact Dermatitis (Eczema, Contact)
11/2018 - 10/2010
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2017 - 04/2014
3Colorectal Neoplasms (Colorectal Cancer)
12/2015 - 07/2003
3Aberrant Crypt Foci
12/2011 - 04/2007
3Urinary Bladder Neoplasms (Bladder Cancer)
12/2010 - 08/2008
3Lymphoma (Lymphomas)
05/2009 - 04/2003
2Pancreatic Neoplasms (Pancreatic Cancer)
11/2021 - 09/2015
2Adenocarcinoma
11/2021 - 12/2015
2Hypoxia (Hypoxemia)
02/2021 - 09/2016
2Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 02/2006
2Kidney Diseases (Kidney Disease)
01/2020 - 09/2016
2Allergic Contact Dermatitis
11/2018 - 01/2014
2Colitis
01/2018 - 04/2012
2Lewis Lung Carcinoma
01/2017 - 08/2009
2Fibrosarcoma
01/2015 - 04/2010
2Sarcoma (Soft Tissue Sarcoma)
01/2015 - 02/2006
2Osteosarcoma (Osteogenic Sarcoma)
01/2015 - 05/2011
2Hyperplasia
05/2013 - 04/2003
2Liver Cirrhosis (Hepatic Cirrhosis)
03/2011 - 04/2008

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
02/2021 - 04/2002
11pterostilbeneIBA
11/2021 - 08/2010
10Reactive Oxygen Species (Oxygen Radicals)IBA
03/2015 - 03/2003
10Arsenic Trioxide (Trisenox)FDA Link
01/2015 - 04/2006
8CaspasesIBA
03/2008 - 07/2003
6Therapeutic UsesIBA
03/2021 - 04/2002
6Messenger RNA (mRNA)IBA
09/2011 - 05/2009
5InflammasomesIBA
01/2022 - 12/2016
5ResveratrolIBA
11/2021 - 03/2008
5CytokinesIBA
01/2020 - 10/2010
5Histone Deacetylase InhibitorsIBA
11/2019 - 04/2014
5ChromiumIBA
11/2018 - 08/2010
5CarcinogensIBA
01/2018 - 06/2005
5SmokeIBA
01/2014 - 06/2005
5Polychlorinated Dibenzodioxins (TCDD)IBA
01/2014 - 09/2005
5NicotineFDA Link
09/2011 - 08/2008
4StilbenesIBA
11/2021 - 03/2008
4chromium hexavalent ionIBA
11/2018 - 10/2010
4AntioxidantsIBA
01/2017 - 08/2010
4Biological ProductsIBA
01/2017 - 01/2011
4anthraceneIBA
06/2013 - 11/2006
4Thioctic Acid (Lipoic Acid)IBA
03/2011 - 06/2007
4Cyclin D3IBA
01/2011 - 04/2002
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2006 - 04/2003
3Oxygen (Dioxygen)IBA
10/2021 - 01/2021
3Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2004
3Histone Deacetylases (Histone Deacetylase)IBA
01/2017 - 01/2013
3DNA (Deoxyribonucleic Acid)IBA
01/2017 - 04/2007
3Protein Kinases (Protein Kinase)IBA
06/2013 - 02/2006
3AndrogensIBA
05/2013 - 01/2012
3Estrogen ReceptorsIBA
01/2013 - 06/2010
3ErbB Receptors (EGF Receptor)IBA
11/2012 - 02/2011
3EnzymesIBA
05/2012 - 05/2005
3dihydrolipoic acidIBA
03/2011 - 06/2007
3Small Interfering RNA (siRNA)IBA
01/2011 - 06/2010
3Terbinafine (Lamisil)FDA LinkGeneric
05/2008 - 08/2003
3Cytochromes c (Cytochrome c)IBA
02/2006 - 07/2003
2Telomerase (Telomerase Reverse Transcriptase)IBA
06/2019 - 10/2017
2TNF Receptor-Associated Factor 6 (TRAF6)IBA
04/2018 - 09/2015
2Dextran SulfateIBA
01/2018 - 04/2012
2TMU-35435IBA
01/2017 - 01/2017
2VorinostatFDA Link
10/2016 - 01/2013
2Proteasome InhibitorsIBA
09/2015 - 01/2015
2Pentachlorophenol (Sodium Pentachlorophenate)IBA
03/2015 - 04/2003
2Mitogen-Activated Protein KinasesIBA
03/2015 - 02/2011
2Acetylcysteine (Siran)FDA LinkGeneric
01/2014 - 08/2010
2StaurosporineIBA
01/2014 - 02/2006
2Caspase 3 (Caspase-3)IBA
01/2014 - 05/2009
24- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA
01/2014 - 02/2011
2Estrogens (Estrogen)FDA Link
01/2014 - 09/2011
2monascuspiloinIBA
07/2012 - 01/2012
2ArsenicIBA
06/2012 - 05/2012
2Thioacetamide (Thioacetamid)IBA
03/2011 - 04/2008
2AzoxymethaneIBA
02/2011 - 08/2010
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2011 - 09/2010
2AgarIBA
01/2011 - 09/2010

Therapy/Procedure

14Drug Therapy (Chemotherapy)
02/2021 - 04/2002
12Therapeutics
01/2021 - 08/2002
7Chemoprevention
01/2014 - 06/2007
3Radiotherapy
11/2019 - 05/2009
3Lasers (Laser)
09/2010 - 05/2009